Welcome to MyStrategist

Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today

Subscribe Browse

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Regulatory & Reimbursement

CDRH Hiring, EU Reform Timeline, AI Policy Plans, and More

In this week’s Pathways Picks: A report from The MedTech Conference in Boston, including insights from FDA, CMS, AMA, EU, and UK officials. Updates on CDRH hiring efforts, EU reform timelines, AI policy moves in the US, UK, and EU, perspectives on the impending FDA-CMS RAPID program, and more from around the world.

Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Investors & Dealmaking

The Digest October 2026

In this month's news, 510(k)s for several AI image analysis tools, Steris buys Xodus Medical for $2.1 billion, developments in the Delphi and READI-Home programs for patient-used products, and more.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

Regulatory & Reimbursement

Pathways' Pick of the Week: RAPID Feedback

Medtech groups formally respond to CMS’ RAPID proposal for regulatory-reimbursement alignment. Excerpted from Pathways Picks October 14: RAPID Response, Notified Body Needs, CDRH Retirement, and More.

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More